Keep up with what's happening in the crypto world in real-time.
All Filters (1)
Injective Protocol (INJ) has emerged as a notable player in the decentralized exchange (DEX) space, built on the Cosmos blockchain. As of July 2024, INJ is trading at $27.19, reflecting the dynamic interplay between technical indicators and broader market trends.
Injective (INJ) has recently captured the spotlight with a remarkable surge in value, marking a significant milestone in the cryptocurrency space. Over the past week, INJ has experienced a notable 32% increase, with a more modest 1% rise in the last 24 hours.
21Shares is now making moves by leaning into the Injective Protocol.
TL;DR Launch of AINJ: 21Shares introduced the Injective Staking Exchange-Traded Product (ETP) on Euronext Amsterdam and Paris, bridging traditional finance and crypto markets. Investment Access: AINJ offers exposure to Injective (INJ) through brokers like Interactive Brokers and eToro, simplifying crypto investments.
Recently, injective (INJ) has undergone explosive growth, pushing itself to unprecedented heights and drawing interest both from experts and bitcoin aficionados. Over the past week, the digital asset has jumped about 32%, and a measly 1% in the last day.
This product offers $INJ exposure through major finance exchanges and brokerages, capturing staking rewards. 21Shares, a primary issuer of crypto ETPs, is at the forefront of this launch.
The market leader, Bitcoin price has recorded a correction of over 2% within the past day. On the other hand, the altcoin leader, Ethereum price has displayed a positive price action by adding approximately 0.10% with a trading volume of $15.304 Billion.
21Shares has unveiled its latest crypto product, the Injective Staking Exchange-Traded Product (ETP) – AINJ. This product aims to enable investors to engage in the crypto market via traditional financial avenues.
Injective Labs, in collaboration with 21Shares, has announced the launch of AINJ — the Injective Staking Exchange-Traded Product (ETP) linked to INJ, which will include staking. The fund will allow users to gain exposure to INJ tokens via major traditional financial exchanges and brokerages while also capturing staking rewards.
INJ takes a spot among the largest cryptos with a financial product exposing it to traditional investors.
21Shares launched AINJ, allowing users INJ exposure and staking rewards on major exchanges.
Injective (INJ)collaborates with 21Shares to launch AINJ, a new staking ETP offering INJ exposure and staking rewards via traditional finance venues.
Injective (INJ) hosted its inaugural Builder House event—a gathering that would redefine collaboration and innovation within the blockchain ecosystem. This milestone event brought together a diverse spectrum of participants, from seasoned developers to visionary industry leaders, all converging with a common purpose: to explore, innovate, and propel the boundaries of decentralized finance (DeFi).
Injective (INJ) price has risen for six consecutive days, its longest winning streak of 2024. It rose by over 12% on Wednesday, making it the best-performing top 50 cryptocurrency.
The price of Injective has increased by over 25% in the past week, from a low of $17 to $23.27 this morning. Recently, the cryptocurrency market has been trending positively, and the substantial increase in Bitcoin's price is a significant factor in this price ascent.
The crypto markets appear to have been taken over by the bulls as the major tokens have risen above their crucial resistance zone. Bitcoin rose above $65,000, while Ethereum was above $3,500, & XRP, which remained passive for quite a while, has soared by over 40% in the past couple of days to reach $0.6.
The inaugural Injective (INJ)Builder House in Brussels during EthCC united developers, industry leaders, and community members, marking a key milestone for Injective.
The cryptocurrency market, known for its volatility, experienced significant peaks and valleys in recent months. One coin that has garnered considerable attention is Injective (INJ).
Injective's (INJ) price, which is trading at $22, is breaching past a crucial resistance level that is also an important support level.
Injective Protocol (INJ) has emerged as a captivating entity in the ever-evolving landscape of cryptocurrencies, attracting considerable attention from analysts and investors alike. Amidst recent market movements, INJ stands at a pivotal juncture with analysts forecasting a potential surge to $36, driven by its unique market positioning and attractive staking rewards.
Injective, or INJ, has lately been causing waves in the crypto scene. Many analysts are hopeful about its future even if it has lately dropped.
With the cryptocurrency market adding approximately $150 Billion in valuation over the past 3 days, the price of Bitcoin has successfully reclaimed the $58,000 mark during the early Asian trading hours today. Moreover, with an increase in bullish sentiment among the top altcoins, the AI category has displayed a similar trend by adding 2.
Ryan Selkis, the head of Messari, has announced that his company is breaking free from the SEC and is now waging a war against it. This is huge news as it could bring more attention to the DeFi market.
Despite the strong downward selling pressure on Bitcoin (BTC) which is currently taking place, there are a few altcoins that have been moving up over the last few days. Both $SOL and $INJ are two of the more fundamentally sound altcoins that are approaching breakouts.
